Manning-Bog A - Search Results

1

Axonal transport of AAV9 in nonhuman primate brain.

Green F, Samaranch L, Zhang HS, Manning-Bog A, Meyer K, Forsayeth J, Bankiewicz KS. Green F, et al. Among authors: manning bog a. Gene Ther. 2016 Jun;23(6):520-6. doi: 10.1038/gt.2016.24. Epub 2016 Mar 8. Gene Ther. 2016. PMID: 26953486 Free PMC article.

2

Anti-Inflammatory and Neuroprotective Effects of PGE₂ EP4 Signaling in Models of Parkinson's Disease.

Pradhan SS, Salinas K, Garduno AC, Johansson JU, Wang Q, Manning-Bog A, Andreasson KI. Pradhan SS, et al. Among authors: manning bog a. J Neuroimmune Pharmacol. 2017 Jun;12(2):292-304. doi: 10.1007/s11481-016-9713-6. Epub 2016 Oct 12. J Neuroimmune Pharmacol. 2017. PMID: 27734267 Free PMC article.

3

Suppression of inflammation with conditional deletion of the prostaglandin E2 EP2 receptor in macrophages and brain microglia.

Johansson JU, Pradhan S, Lokteva LA, Woodling NS, Ko N, Brown HD, Wang Q, Loh C, Cekanaviciute E, Buckwalter M, Manning-Bog AB, Andreasson KI. Johansson JU, et al. Among authors: manning bog ab. J Neurosci. 2013 Oct 2;33(40):16016-32. doi: 10.1523/JNEUROSCI.2203-13.2013. J Neurosci. 2013. PMID: 24089506 Free PMC article.

4

Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.

Woodling NS, Colas D, Wang Q, Minhas P, Panchal M, Liang X, Mhatre SD, Brown H, Ko N, Zagol-Ikapitte I, van der Hart M, Khroyan TV, Chuluun B, Priyam PG, Milne GL, Rassoulpour A, Boutaud O, Manning-Boğ AB, Heller HC, Andreasson KI. Woodling NS, et al. Among authors: manning bog ab. Brain. 2016 Jul;139(Pt 7):2063-81. doi: 10.1093/brain/aww117. Epub 2016 May 13. Brain. 2016. PMID: 27190010 Free PMC article.

5

Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.

Chou VP, Ko N, Holman TR, Manning-Boğ AB. Chou VP, et al. Among authors: manning bog ab. J Vis Exp. 2014 Jan 7;(83):e50960. doi: 10.3791/50960. J Vis Exp. 2014. PMID: 24430802 Free PMC article.

6

Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Chou VP, Holman TR, Manning-Bog AB. Chou VP, et al. Neuroscience. 2013 Jan 3;228:73-82. doi: 10.1016/j.neuroscience.2012.10.009. Epub 2012 Oct 16. Neuroscience. 2013. PMID: 23079635 Free PMC article.

7

Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease.

Tate CC, Chou VP, Campos C, Moalem AS, Di Monte DA, McGrogan M, Case CC, Manning-Bog AB. Tate CC, et al. Among authors: manning bog ab. J Tissue Eng Regen Med. 2017 Jun;11(6):1835-1843. doi: 10.1002/term.2081. Epub 2015 Oct 6. J Tissue Eng Regen Med. 2017. PMID: 26440859

8

Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.

Manning-Bog AB, McCormack AL, Purisai MG, Bolin LM, Di Monte DA. Manning-Bog AB, et al. J Neurosci. 2003 Apr 15;23(8):3095-9. doi: 10.1523/JNEUROSCI.23-08-03095.2003. J Neurosci. 2003. PMID: 12716914 Free PMC article.

9

Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.

Shchepinov MS, Chou VP, Pollock E, Langston JW, Cantor CR, Molinari RJ, Manning-Boğ AB. Shchepinov MS, et al. Toxicol Lett. 2011 Nov 30;207(2):97-103. doi: 10.1016/j.toxlet.2011.07.020. Epub 2011 Aug 10. Toxicol Lett. 2011. PMID: 21906664

10

Environmental factors in Parkinson's disease.

Di Monte DA, Lavasani M, Manning-Bog AB. Di Monte DA, et al. Neurotoxicology. 2002 Oct;23(4-5):487-502. doi: 10.1016/s0161-813x(02)00099-2. Neurotoxicology. 2002. PMID: 12428721 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page